Skip to content

Next generation phenotyping in essential tremor

Next generation phenotyping in essential tremor - NG-PIET

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49466
Enrollment
100
Registered
2020-03-23
Start date
2020-10-12
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

essential tremor tremor

Interventions

None listed

Sponsors

Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - For the index patient: diagnosis of essential tremor syndrome by neurologist, in line with the consensus statement put forward by the Tremor Investigation Group of the Movement Disorders Society and a minimum age of 18 years. - For the family: a minimum of 3 affected relatives, belonging to a minimum of 2 generations, willing to participate.

Exclusion criteria

Exclusion criteria: - Part A, if the patient has a silver allergy - Part A, if the patient has a pacemaker - Part B, if the patients alcohol history is indicative of (previous) alcohol abuse - Part B, if the patient is pregnant or breastfeeding - Part B, if the patient uses medication which is contraindicated in combination with alcohol

Design outcomes

Primary

MeasureTime frame
In this study we will try to identify a familial phenotype of essential tremor in our population, based on clusters of the discovered familial features. Based on our recently published review (4) we will address the following features of interest: age at onset, cranial tremor, dystonia, alcohol responsivity and tremor frequency.

Secondary

MeasureTime frame
Features of secondary interest are: - Disease progression - Cerebellar signs (intention tremor via finger-to-nose manoeuvres, via finger-to-finger manoeuvres, tandem gait difficulty) - Parkinsonism (bradykinesia, rigidity) - Tremor severity (Fahn-Tolosa-Marin Essential Tremor Rating Scale part A and B, visual analogue scale) - Neurophysiological features (frequency variability, coherence analysis) - Discrepancies between self-reported and test-based alcohol responsivity

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)